NCT07432295
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07432295
Title Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Acronym GIVA-2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors I-Mab Biopharma US Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
I-Mab Site 1016 RECRUITING Goodyear Arizona 85338 United States Details
I-MAB Site 1005 RECRUITING Duarte California 91010 United States Details
I-Mab Site 1013 RECRUITING Sugarland Texas 77479 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field